Antenatal care attendees positive for syphilis who received treatment in Mus
Mus: Antenatal care attendees positive for syphilis who received treatment was 100.0% in 2019. ▬ Flat
Latest (2019)
100.0%
Change on year
unchanged
Rank
1st
of 1 regions
All-time high
100.0%
in 2011
All-time low
100.0%
in 2011
Years of data
9
2011–2019
Antenatal care attendees positive for syphilis who received treatment in Mus, 2011–2019
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for antenatal care attendees positive for syphilis who received treatment in Mus is 100.0%, measured in 2019. That is the highest value across all 9 years on record.
The figure is unchanged over ten years.
Over the whole period, antenatal care attendees positive for syphilis who received treatment in Mus peaked at 100.0% in 2011 and was at its lowest, 100.0%, in 2011.
Antenatal care attendees positive for syphilis who received treatment in Mus, year by year
| Year | Value | Change |
|---|---|---|
| 2011 | 100.0% | — |
| 2012 | 100.0% | +0.0% |
| 2013 | 100.0% | +0.0% |
| 2014 | 100.0% | +0.0% |
| 2015 | 100.0% | +0.0% |
| 2016 | 100.0% | +0.0% |
| 2017 | 100.0% | +0.0% |
| 2018 | 100.0% | +0.0% |
| 2019 | 100.0% | +0.0% |
Countries ranked near Mus
- 1 Benin 100.0% compare
- 1 Belarus 100.0% compare
- 1 Ghana 100.0% compare
- 1 Oman 100.0% compare
- 1 Bahamas 100.0% compare
- 1 Eritrea 100.0% compare
- 1 Marshall Islands 100.0% compare
- 1 Guatemala 100.0% compare
- 1 Saudi Arabia 100.0% compare
- 1 Nigeria 100.0% compare
- 1 Mongolia 100.0% compare
- 1 United Arab Emirates 100.0% compare
- 1 Bolivia, Plurinational State of 100.0% compare
- 1 Zambia 100.0% compare
- 1 Barbados 100.0% compare
- 1 Samoa 100.0% compare
- 1 Ukraine 100.0% compare
- 1 Niger 100.0% compare
- 1 Kiribati 100.0% compare
- 1 Kyrgyzstan 100.0% compare
- 1 Iran, Islamic Republic of 100.0%
- 1 Malawi 100.0% compare
- 1 Nicaragua 100.0% compare
- 1 Antigua and Barbuda 100.0% compare
- 1 South Sudan 100.0%
- 1 Sao Tome and Principe 100.0% compare
- 1 Bangladesh 100.0% compare
- 1 Seychelles 100.0% compare
- 1 Mauritius 100.0% compare
- 1 Tajikistan 100.0% compare
More health data for Mus
- Pertussis - number of reported cases, gaps filled 0 (2025)
- Pertussis - number of reported cases, annual growth rate -100 % change on previous year (2011)
- Measles - number of reported cases 0 (2025)
- Diphtheria - number of reported cases 0 (2025)
- Pertussis - number of reported cases 0 (2025)
- Total tetanus - number of reported cases 0 (2025)
- Neonatal tetanus - number of reported cases 0 (2025)
- Infant mortality rate (probability of dying between birth and age 1) 13.82 (2024)
- Overweight among adults, BMI ≥ 25 kg/m2 (crude estimate) 54.3% (2024)
- Obesity among adults, BMI ≥ 30 kg/m2 (age-standardized estimate) 21.1% (2024)
Frequently asked questions
- What is antenatal care attendees positive for syphilis who received treatment in Mus?
- Antenatal care attendees positive for syphilis who received treatment in Mus was 100.0% in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest antenatal care attendees positive for syphilis who received treatment recorded in Mus?
- The highest recorded value was 100.0% in 2011.
- What is the lowest antenatal care attendees positive for syphilis who received treatment recorded in Mus?
- The lowest recorded value was 100.0% in 2011.
- How does Mus rank for antenatal care attendees positive for syphilis who received treatment?
- Mus ranks 1st out of 1 regions with data for 2019.
- Is antenatal care attendees positive for syphilis who received treatment rising or falling in Mus?
- Over the last ten years it is unchanged. The long-run trend across the full record is flat.
- Where does this Mus data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Antenatal care attendees positive for syphilis who received treatment (%), reported. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).